http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2716749-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d584042a524740a406723fe1631e49e5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96db44d6641b0d96e4152e2aac6353f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13157b34ef2e8ff18fa5c11dca3045f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24804e89b425c7af0e9928716e14e77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c30837b7a42c8d1629db22ed5ae7e2c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f931b0be6cf24b635e6967516e391e95 |
| publicationDate | 2020-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2716749-C1 |
| titleOfInvention | Method for predicting the progression of chronic cardiac failure within a year after a previous myocardial infarction |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used to predict progression of chronic cardiac failure (CCF) within one year after a previous myocardial infarction. In 6 months after myocardial infarction, blood is sampled and erythrocyte beta adrenoreactivity is determined. If observing erythrocyte adrenoreactivity values – β-ARM is more than or equal to 49.53 standard units, progression of chronic cardiac failure is predicted. If observing values of β-ARM below 49.53 standard units, predicted favorable course of disease.EFFECT: method provides more accurate prediction of CCF progression within a year after myocardial infarction by evaluating the β-ARM, which is an early predictor of CCF progression in the patients.1 cl, 1 dwg, 1 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2752362-C1 |
| priorityDate | 2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.